Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016–2017 Season: Insights Into Novel Age-Specific Analysis
Author(s) -
Yaniv Stein,
Michal Mandelboim,
Hanna Sefty,
Rakefet Pando,
Ella Mendelson,
Tamy Shohat,
Aharona GlatmanFreedman,
Affawi Muhamed,
Akerman Arkadi,
Alkan Yoav,
Amsel Shlomo,
Asala Galab,
Dinkin Lev,
Fradkin Akiva,
Ginzburg Michael,
Haj-Daud Ali,
Hashivon Kamil,
Hess Yael,
Kalminsky Ella,
K. C. Angela,
Laks Yoseph,
Levenstein Tali,
Lustman Alexander,
Mansour Washahi Nadia,
M. Nir,
Mazor Oded,
Meshulach Idit,
Neimark Margarita,
Perga-Menzov Shiri,
Rechavi Karen,
Segal Nirit,
Shlank Eva,
Singer Rephael,
Slater Paul,
Yunes Ronen,
Zivner Ran
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1013
Subject(s) - medicine , influenza vaccine , confidence interval , population , influenza season , influenza a virus , seasonal influenza , vaccination , age groups , demography , immunology , virus , environmental health , covid-19 , disease , infectious disease (medical specialty) , sociology
The 2016-2017 influenza season in Israel was dominated by the circulation of influenza A(H3N2). Influenza vaccine is recommended for the entire population in Israel aged >6 months. The inactivated influenza vaccine was chosen for use this season.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom